Fassbender, M (6 March 2017). Safety implications of GCP loophole 'very concerning,' says IAOCR. Outsourcing-Pharma.com
Lees verder
|
Tsang, L., Kracov, D.A. & Young, C.A. (6 March 2017). Impact of the EU-US Mutual Recognition Agreement on Pharmaceutical Product Inspections. Arnold & Porter Kaye Scholer LLP, blog.
Lees verder
|
EFPIA, EuropaBio, Medicines for Europe (27 February 2017). Joint letter regarding the criteria for the re-location of the EMA in the context of the Conduct of the Negotiations with the UK under Article 50 TFEU. (2 maart 2017). Public.
Lees verder
|
PIC/S takes strong stance on European Commission's proposed stand-alone ATMP GMP Guidelines (2 March 2017)
Lees verder
|
EMA Press release (2 March 2017). European and US regulators agree on mutual recognition of inspections of medicines manufacturers.
Lees verder
|
EFPIA, EUCOPE and EuropaBio welcome the Publication of the European Commission’s Study on Off-Label Use and call for policy measures that preserve patients’ safety and the integrity of the EU regulatory regime (2 March 2017).
Lees verder
|
Study on off label use of medicinal products in the European Union by Nivel, National Institute for Public Health and the Environment and EPHA (February 2017).
Lees verder
|
The EU General Data Protection Regulation. Answers to Frequently Asked Questions Updated Version 2.0. Prepared by the BBMRI-ERIC Common Service ELSI March 1, 2017
Lees verder
|
Black, H. (1 March 2017). Commission launches reference networks to face rare and complex diseases. EURACTIV.com
Lees verder
|
Persbericht European Commission (28 February 2017). Commission simplifies Horizon 2020.
Lees verder
|
Brookshire, B. (28 February 2017). Scientists may work to prevent bias, but they don’t always say so. ScienceNews.
Lees verder
|
Nguyen, Tri-Long et al. (28 February 2017). Simple Randomization Did not Protect Against Bias in Smaller Trials. Journal of Clinical Epidemiology.
Lees verder
|
Stern, V. (27 February 2017). Authors couldn’t find a patient to give consent for case report. Then the patient found the report. Retraction Watch
Lees verder
|
The National Academies of Sciences, Engineering & Medicine (14 February 2017). With Stringent Oversight, Heritable Germline Editing Clinical Trials Could One Day Be Permitted for Serious Conditions; Non-Heritable Clinical Trials Should Be Limited to Treating or Preventing Disease or Disability at This Time.
Lees verder
|
MedicijnBalans (23 februari 2017). Zorgverleners stellen hoge eisen aan klinische relevantie. Instituut voor Verantwoord Medicijngebruik.
Lees verder
|
Mogil, J.S. & Macleod, M.R. (22 February 2017). No publication without confirmation. Nature 542, 409–411 doi:10.1038/542409a
Lees verder
|
Kilicoglu, H. (14 February 2017). Biomedical Text Mining for Research Rigor and Integrity: Tasks, Challenges, Directions. Preprint & not been peer-reviewed. bioRxiv 108480
Lees verder
|
Zeiss CJ, Allore HG, Beck AP (2017) Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson’s disease. PLOS ONE 12(2): e0171790. doi: 10.1371/journal.pone.0171790
Lees verder
|
Loder, E. (8 February 2017). The persistent problem of unregistered clinical trials. The BMJ Opinion.
Lees verder
|
Allen, A. (8 February 2017). Do we have the right guinea pigs? Politico.
Lees verder
|
Breckenridge, A., Aronson, J.K., Blaschke, T.F., Hartman, D., Peck, C.C. & Vrijens B. (3 February 2017). Poor medication adherence in clinical trials: consequences and solutions. Nature Reviews Drug Discovery 16, 149–150 doi:10.1038/nrd.2017.1
Lees verder
|
ECRIN (31 January 2017) Press release: Towards better medicines for children: PedCRIN project builds research infrastructure.
Lees verder
|
Dunleavy, P. (25 January 2017). How to write a blogpost from your journal article in eleven easy steps. The London School of Economics and Political Science, The Impact Blog.
Lees verder
|
EMA (13 January 2017). Work plan for the GMP/GDP Inspectors Working Group for 2017.
Lees verder
|
EU GLP Working Group. GLP Compliance Monitoring of International Multi-Site Studies, adopted by the EU GLP Working Group on 5 January 2017.
Lees verder
|
Abbasi J. Public-Private Partnership Speeds Investigator Access to Cancer Drugs. JAMA. 2017;317(8):797. doi:10.1001/jama.2017.1089
Lees verder
|
Borah R, et al. Analysis of the time and workers needed to conduct systematic reviews of medical interventions using data from the PROSPERO registry. BMJ Open 2017;7:e012545. doi:10.1136/bmjopen-2016-012545
Lees verder
|
Von Niederhäusern, B., Orleth, A., Schädelin, S., Rawi, N., Velkopolszky, M., Becherer, C., … Pauli-Magnus, C. (2017). Generating evidence on a risk-based monitoring approach in the academic setting – lessons learned. BMC Medical Research Methodology, 17, 26.
Lees verder
|
Harriman, S.L. & Patel, J. (15 April 2016). When are clinical trials registered? An analysis of prospective versus retrospective registration. Trials 2016 17:187 DOI: 10.1186/s13063-016-1310-8
Lees verder
|
Llewellyn-Bennett, R., Bowman, L. & Bulbulia, R. (2016). Post-trial follow-up methodology in large randomized controlled trials: a systematic review protocol. Systematic Reviews 5:214 DOI: 10.1186/s13643-016-0393-3
Lees verder
|
Motivations of minors and their parents to consent or dissent to participation in paediatric clinical research - Verslagen - ZonMw
Lees verder
|